Anal Carcinoma Therapy: Can We Improve on 5-Fluorouracil/Mitomycin/Radiotherapy?

Author： Jiang Yixing   Mackley Heath   Cheng Hua   Ajani Jaffer A.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.8, Iss.1, 2010-01, pp. : 135-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin should not replace mitomycin when administered with fluorouracil and radiotherapy in patients with anal cancer

By  

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Multimodal Keloid Therapy with Excision, Application of Mitomycin C, and Radiotherapy

By Willett Matthew   Handfield Kent   Marquart Jason  

Dermatologic Surgery, Vol. 40, Iss. 4, 2014-04 ,pp. : 480-482

Elsevier

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

By Demchuk Andrew M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1833-1845

Adis International

Access to resources Recommend Favorite

Pharmacokinetic adaptation of 5-fluorouracil: where are we and where are we going?

By Boisdron-Celle Michèle  

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1437-1439

Future Medicine

Access to resources Recommend Favorite

Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil?

By Young A.M.   Daryanani S.   Kerr D.J.  

Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. : 391-398

Adis International

Access to resources Recommend Favorite